var  groupallo = {
    "feature_count": 714,
    "type": [
        "FeatureCollection"
    ],
    "features": [
        {
            "type": "Feature",
            "properties": {
                "name": "A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-101 Clinical Trial",
                "aff": "Hallym university Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03183622",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 106, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2015-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease",
                "aff": "Yonsei University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02580617",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 65, 53)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2015-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers",
                "aff": "University of Southern California, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04497805",
                "enrolled": 64,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 106, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2020-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.28586662125,
                    34.0218833
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of ALLO-ASC-DFU in the Patients With Diabetic Foot Ulcers",
                "aff": "Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02394886",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 97, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2014-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Foot Ulcers",
                "aff": "University of Southern California, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03754465",
                "enrolled": 56,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 103, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2019-01-02",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.28586662125,
                    34.0218833
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-201 Clinical Trial",
                "aff": "Hallym university Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03183648",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 92, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2016-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers.",
                "aff": "Korea University Kuro Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03370874",
                "enrolled": 164,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 69, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2018-07-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers",
                "aff": "Korea University Guro Hospital, Guro-gu, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02619877",
                "enrolled": 59,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 59, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    126.89037652807453,
                    37.48619975
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers",
                "aff": "Eulji General Hospital, Nowon-Gu, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02619877",
                "enrolled": 59,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 59, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers",
                "aff": "Severance Hospital, Seodaemun-Gu, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02619877",
                "enrolled": 59,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 59, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers",
                "aff": "Asan medical center, Songpa-Gu, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02619877",
                "enrolled": 59,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 59, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn Wound",
                "aff": "Hallym university Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02394873",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 89, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2015-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Fecal Incontinence Using Allogenic-Adipose-derived Mesenchymal Stem Cells: A Prospective, Dose Escalation, Randomized, Placebo-controlled, Parallel-group, Single-blind, Single-center Pilot Study",
                "aff": "Section of Colon and Rectal Surger, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02384499",
                "enrolled": 21,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 53)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects",
                "aff": "Hallym university Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02619851",
                "enrolled": 22,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 78, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2015-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC)",
                "aff": "Seoul National University Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03449082",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 88, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2018-05-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Tendon Injury Using Mesenchymal Stem Cells",
                "aff": "Seoul National University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01856140",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 90, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2013-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis",
                "aff": "Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02131077",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 101, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis",
                "aff": "Chung-Ang University Hosptal, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02131077",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 101, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis",
                "aff": "Gangnam Severance Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02131077",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 101, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis",
                "aff": "Nanoori hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02131077",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 101, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis",
                "aff": "Samsung medical center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02131077",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 101, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis",
                "aff": "Seoul National University Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02131077",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 101, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic HUman Mesenchymal Stem Cell InfusioN Versus Placebo in Subjects With Alcohol Use Disorder and Major DepreSsion.",
                "aff": "University of Texas Rio Grande Valley School of Medicine, Harlingen, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03265808",
                "enrolled": 28,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 76, 15)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2018-03-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97.6960599,
                    26.1907543
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis Pilot Study (The POSEIDON-Pilot Study)",
                "aff": "University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01087996",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 60, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2010-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis Pilot Study (The POSEIDON-Pilot Study)",
                "aff": "Johns Hopkins University, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01087996",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 60, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2010-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.62185357858337,
                    39.33020225
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery",
                "aff": "ISCI/University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02065245",
                "enrolled": 65,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 89, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2014-03-03",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects",
                "aff": "University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02886884",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-09-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study)",
                "aff": "ISCI / University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02013674",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 81, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-02-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy",
                "aff": "Stanford University, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04476901",
                "enrolled": 136,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 102, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12979,
                "paneLabel": "pane12979",
                "start": "2021-05-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.16936535498309,
                    37.43131385
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy",
                "aff": "University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04476901",
                "enrolled": 136,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 102, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12979,
                "paneLabel": "pane12979",
                "start": "2021-05-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy",
                "aff": "University of Louisville, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04476901",
                "enrolled": 136,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 102, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12979,
                "paneLabel": "pane12979",
                "start": "2021-05-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85.75770751081866,
                    38.21332235
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy",
                "aff": "Texas Heart Institute, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04476901",
                "enrolled": 136,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 102, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12979,
                "paneLabel": "pane12979",
                "start": "2021-05-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.399419,
                    29.7079305
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell.",
                "aff": "Grupo Espanol de trasplantes hematopoyeticos y terapia celular, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01956903",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 91, 49)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2010-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3.7035825,
                    40.4167047
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)",
                "aff": "Hospital Clinico Universitario, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01860417",
                "enrolled": 25,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 82, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2013-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4.718737949587745,
                    41.656005750000006
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)",
                "aff": "Instituto de Biologia y Genetica Molecular, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01860417",
                "enrolled": 25,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 82, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2013-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4.717452260190187,
                    41.65580325
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells",
                "aff": "Centro Medico Teknon, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01586312",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 83, 13)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2012-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2.123970972001783,
                    41.39143835
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells",
                "aff": "Hospital Clinico Universitario, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01586312",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 83, 13)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2012-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4.718737949587745,
                    41.656005750000006
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial",
                "aff": "University Hospital La Paz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01678534",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 98, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3.7035825,
                    40.4167047
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.",
                "aff": "Hospital de Jerez de la Frontera., Jerez de la Frontera, C\u00e1diz., Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01222039",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 91, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2010-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -8.9156122,
                    42.8734659
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.",
                "aff": "Hospital Universitario Virgen de las Nieves, Granada., Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01222039",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 91, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2010-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3.6071805571518736,
                    37.1929345
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.",
                "aff": "Hospital Universitario Virgen del Roc\u00edo de Sevilla, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01222039",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 91, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2010-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5.9953403,
                    37.3886303
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.",
                "aff": "Hospital Cl\u00ednico de Valencia, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01222039",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 91, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2010-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -0.3763353,
                    39.4697065
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease",
                "aff": "Hospital Universitario Valle de Hebr\u00f3n, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05521672",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 92, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2.1774322,
                    41.3828939
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease",
                "aff": "Hospital Universitario Fundaci\u00f3n Jim\u00e9nez Diaz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05521672",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 92, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3.7035825,
                    40.4167047
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease",
                "aff": "Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05521672",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 92, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -0.3763353,
                    39.4697065
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment",
                "aff": "Cell Therapy Center, University of Jordan, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT03326505",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 89, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2017-08-25",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35.87338209486857,
                    32.013409249999995
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment",
                "aff": "Cell Therapy Center, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT03326505",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 89, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2017-08-25",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35.9239625,
                    31.9515694
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Centre for Liver Research & Diagnostics, Hyderabad, Andhra Pradesh, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 86, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    78.0267508,
                    15.8142734
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Mediciti Hospital, Hyderabad, Andhra Pradesh, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 86, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    78.0267508,
                    15.8142734
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Manipal Hospital, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 86, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77.5938727,
                    13.0509925
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "KMC Hospital, Mangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 86, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    74.8480016484457,
                    12.85885905
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Institute of liver disease, HPB surgery and transplant Global Hospitals, Mumbai, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 86, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    72.878176,
                    19.0785451
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Bombay Hospital & Medical Research Center, Mumbai, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 86, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    72.878176,
                    19.0785451
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Ruby Hall clinic, Pune, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 86, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    73.87716013420717,
                    18.5336353
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Sahyadri Speciality Hospital, Pune, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 86, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    73.8971383,
                    18.5543086
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "SMS Medical college and Hospital, Jaipur, Rajasthan, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 86, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    75.8189817,
                    26.9154576
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "SGPGI Lucknow, Lucknow, Uttar Pradesh, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 86, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    80.9360624,
                    26.7464155
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease",
                "aff": "Taipei Veterans General Hospital, Taipei, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT02336646",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 93, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2015-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.51972186894156,
                    25.1210087
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells",
                "aff": "Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus",
                "url": "https://ClinicalTrials.gov/show/NCT04382547",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 76, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-05-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    27.5618225,
                    53.9024716
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression",
                "aff": "The University of Texas Health Science Center at Houston, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03522545",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 68, 28)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2021-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.3676974,
                    29.7589382
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells",
                "aff": "Saint-Louis Hospital, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT02213705",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 60, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-05-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2.367700706209151,
                    48.87382745
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome",
                "aff": "University of California San Francisco Medical Center, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01775774",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 72, 35)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.419906,
                    37.7790262
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome",
                "aff": "Stanford University Medical Center, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01775774",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 72, 35)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.17030545534064,
                    37.4265407
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01775774",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 72, 35)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.06875296664998,
                    42.36286045
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome",
                "aff": "University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01775774",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 72, 35)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.6243098,
                    40.3693889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke",
                "aff": "Mercy Gilbert and Chandler Medical Center, Gilbert, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01297413",
                "enrolled": 38,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 89, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2011-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111.7890373,
                    33.3527632
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke",
                "aff": "University of California Irvine Department of Neurology, Orange, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01297413",
                "enrolled": 38,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 89, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2011-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.8704931,
                    33.7500378
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke",
                "aff": "University of California San Diego Division of Neurological Surgery, San Diego, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01297413",
                "enrolled": 38,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 89, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2011-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.1627728,
                    32.7174202
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04776239",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 102, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2021-01-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.27870688083459,
                    25.71727245
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells",
                "aff": "University of Illinois, Department of Ophthalmology and Visual Sciences, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04626583",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 86, 53)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-03-05",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.6244212,
                    41.8755616
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Clinica Universitaria de Navarra, Av Pio XII ,36, Pamplona, Navarra, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 60, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2016-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1.6642959885309303,
                    42.8058167
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Hospital Universitario Reina Sof\u00eda, C\u00f3rdoba, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 60, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2016-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4.8379791,
                    39.3260685
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Hospital Cl\u00ednico Universitario Virgen de la Arrixaca, Murcia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 60, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2016-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1.1305431,
                    37.9923795
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Hospital Regional Universitario de M\u00e1laga, M\u00e1laga, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 60, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2016-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4.8379791,
                    39.3260685
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Hospital clinico universitario de salamanca, Salamanca, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 60, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2016-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5.675433931406962,
                    40.96377355
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Virgen del Rocio University Hospital, av. Manuel Siurot s/n, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 60, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2016-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5.9853438,
                    37.3680642
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "University of California San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 104, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2014-03-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.45825681806237,
                    37.7627257
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "Stanford University, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 104, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2014-03-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.16936535498309,
                    37.43131385
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 104, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2014-03-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.06875296664998,
                    42.36286045
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "University of Minnesota Medical Center, Saint Paul, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 104, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2014-03-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93.0931028,
                    44.9497487
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "Ohio State University, Columbus, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 104, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2014-03-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.02866465596318,
                    40.00570905
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 104, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2014-03-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.96246095144505,
                    40.44415295
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10757 - Cardiology, P.C., Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.8024326,
                    33.5206824
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13262 - University of Alabama at Birmingham Hospital, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.8024326,
                    33.5206824
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10779 - Mercy Gilbert Medical Center, Gilbert, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111.7890373,
                    33.3527632
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10786 - Cardiovascular Associates of Mesa, Mesa, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111.8314792,
                    33.4151117
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10756 - Mayo Clinic, Phoenix, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -112.074141,
                    33.4484367
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13023 - University of Arizona Medical Center, Tucson, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -110.9748477,
                    32.2228765
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10754 - University of California, San Diego, La Jolla, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.23112468377349,
                    32.87924375
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10759 - Scripps Clinic, La Jolla, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.2740777,
                    32.8401623
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13265 - University of California, Los Angeles, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.242766,
                    34.0536909
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10775 - Cedars-Sinai Medical Care Foundation, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.242766,
                    34.0536909
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10778 - Orange County Cardiology, Orange, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.8704931,
                    33.7500378
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13031 - St. John's Regional Medical Center, Oxnard, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -119.1803818,
                    34.1976308
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13275 - Stanford University Hospital, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.17030545534064,
                    37.4265407
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13267 - Bethesda Heart Hospital, Boynton Beach, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.0666026,
                    26.5256179
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10780 - Morton Plant Hospital, Clearwater, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.8001026,
                    27.9658533
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10760 - Shands Hospital, University of Florida, Gainesville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.34901329340119,
                    29.6328784
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13273 - University of Florida Health, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.655651,
                    30.3321838
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10768 - University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13280, Orlando, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.3790304,
                    28.5421109
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13264 - Florida Hospital Pepin Heart Institute, Tampa, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.458444,
                    27.9477595
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13027 - Emory University School of Medicine, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.3902644,
                    33.7489924
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10765 - Georgia Regents University, Augusta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.9748429,
                    33.4709714
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10772 - University Cardiologist, Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.66910060446992,
                    41.87352605
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13030 - University of Iowa, Iowa City, Iowa, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91.5299106,
                    41.6612561
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10783 - Gill Heart Institute, University of Kentucky, Lexington, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.5048374161113,
                    38.027038
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13022 - University of Louisville, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85.759407,
                    38.2542376
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13266, New Orleans, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.0782127,
                    29.9759983
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10782, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.060511,
                    42.3554334
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10766 - Michigan Cardiovascular Institute, Saginaw, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.9490365,
                    43.4200387
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10762 - Minneapolis Heart Institute, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93.2654692,
                    44.9772995
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10761 - Mayo Clinic, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92.4630182,
                    44.0234387
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13281, Las Vegas, Nevada, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.148516,
                    36.1672559
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13263 - RWJ Barnabas Heart Center, Newark, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74.1723667,
                    40.735657
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10776 - Columbia University Medical Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13026 - Sanger Heart and Vascular Institute, Carolinas Healthcare System, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.74737175036097,
                    35.3057976
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10781 - Duke University, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.9018053,
                    35.996653
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10758 - The Christ Hospital, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.5124602,
                    39.1014537
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10770 - University of Cincinnati, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.5124602,
                    39.1014537
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10773, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.6936813,
                    41.4996562
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13278 - OhioHealth Research Institute, Columbus, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.0007065,
                    39.9622601
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10785 - Lehigh Valley Hospital, Allentown, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.4712794,
                    40.6022059
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13261 - University of Pennsylvania, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.1635262,
                    39.9527237
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10767 - Temple University Hospital, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.1635262,
                    39.9527237
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13277, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.1635262,
                    39.9527237
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10774 - University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.6243098,
                    40.3693889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10777 - Stern Cardiovascular Foundation, Germantown, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.8100858,
                    35.0867577
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13024 - Austin Heart, PLLC, Austin, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97.8267724,
                    30.3068274
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13274 - Soltero CV Research Center, Baylor Scott & White Research Institute, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.7968559,
                    32.7762719
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10755 - Texas Heart Institute, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.3676974,
                    29.7589382
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13268 - Houston Methodist Hospital, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.3676974,
                    29.7589382
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10763 - University Hospital, Salt Lake City, Utah, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111.8867975,
                    40.7596198
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10771 - Heart & Vascular Research, Swedish Medical Center, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.31090400090532,
                    47.60711215
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10764 - University of Wisconsin, Madison, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.3837613,
                    43.074761
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10769 - Aurora Healthcare, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.922497,
                    43.0349931
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13279, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.922497,
                    43.0349931
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10789 - Aspirus Research Institute, Wausau, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.6298239,
                    44.9596017
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 11027, Edmonton, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -113.491241,
                    53.5462055
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 11024 - Victoria Heart Institute Foundation, Victoria, British Columbia, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -123.3649533,
                    48.4283182
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 11025 - St. Michael's Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 76, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.3839347,
                    43.6534817
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI)",
                "aff": "Mayo Clinic in Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04388761",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 64, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-08-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.44858105666715,
                    30.2588308
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease",
                "aff": "Children's National Medical Center, Washington, District of Columbia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02150551",
                "enrolled": 1,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 91, 13)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12989,
                "paneLabel": "pane12989",
                "start": "2015-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.01397879086224,
                    38.927021
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Bone Marrow Mesenchymal Stem Cells for Patients With Interstitial Lung Disease (ILD) & Connective Tissue Disorders (CTD)",
                "aff": "Mayo Clinic in Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03929120",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 62, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-10-05",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.44858105666715,
                    30.2588308
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05286255",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 66, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2022-05-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.94714193501349,
                    32.7842965
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cellular Immunotherapy for Septic Shock: A Phase I Trial",
                "aff": "The Ottawa Hospital, Ottawa, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT02421484",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 63, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2015-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.64648499814479,
                    45.40180795
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital General de Alicante, Alicante, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 72, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -0.4859102161254462,
                    38.3632372
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Gregorio Mara\u00f1on, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 72, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3.7035825,
                    40.4167047
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 72, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3.7035825,
                    40.4167047
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "La Paz University Hospital, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 72, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3.7035825,
                    40.4167047
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Clinico Universitario Virgen de la Arrixaca, Murcia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 72, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1.1625427931490806,
                    37.93215975
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Clinica Universidad de Navarra, Pamplona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 72, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1.6642959885309303,
                    42.8058167
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Universitario de Salamanca, Salamanca, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 72, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5.6759707297806425,
                    40.96293715
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Victoria Eugenia Cruz Roja Espa\u00f1ola, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 72, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5.9953403,
                    37.3886303
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Universitario La Fe, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 72, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -0.3904493,
                    39.4837878
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital de Valladolid, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 72, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4.7169108,
                    41.6570882
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth",
                "aff": "Department of Otolaryngology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark",
                "url": "https://ClinicalTrials.gov/show/NCT03874572",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 59, 55)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-03-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12.591076889344563,
                    55.65965525
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth",
                "aff": "Department of Otolaryngology, Rigshospitalet, Copenhagen, Denmark",
                "url": "https://ClinicalTrials.gov/show/NCT03874572",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 59, 55)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-03-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12.566645251517794,
                    55.69658685
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells (Rotator Cuff Tear)",
                "aff": "Seoul National University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02298023",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 66, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells",
                "aff": "Taipei Veterans General Hospital, Taipei, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT01649687",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 88, 28)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2012-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.51972186894156,
                    25.1210087
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, C\u00e1diz, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 95, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -8.9156122,
                    42.8734659
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Reina Sof\u00eda, C\u00f3rdoba, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 95, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4.8379791,
                    39.3260685
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Universitario Virgen de las Nieves, Granada, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 95, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3.6071805571518736,
                    37.1929345
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Universitario Virgen Macarena, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 95, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5.986849978407201,
                    37.40675795
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Unversitario Virgen del Roc\u00edo, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 95, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5.9953403,
                    37.3886303
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Nuestra Se\u00f1ora de Valme, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 95, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5.9953403,
                    37.3886303
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Pinnacle Research Group, Anniston, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85.8283224,
                    33.6624824
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Arthrocare Arthritis Care and Research PC, Gilbert, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111.7890373,
                    33.3527632
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Triwest Research Associates, El Cajon, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -116.962526,
                    32.7947731
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "UCLA, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.44685070595054,
                    34.070877749999994
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Inland Rheumatology Clinical Trials Incorporated, Upland, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.6483876,
                    34.09751
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Ocala Rheumatology Research Center, Ocala, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.1400923,
                    29.1871986
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Arthritis Center, Palm Harbor, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.75690699742961,
                    28.0856815
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Sarasota Arthritis Research Center, Sarasota, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.5308545,
                    27.3365805
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "McIlwain Medical Group, Tampa, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.458444,
                    27.9477595
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "JHU Arthritis Center Baltimore, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.610759,
                    39.2908816
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Arthritis Treatment Center, Frederick, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.4127562,
                    39.415779
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Reliant Medical Group, Worcester, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.8012739394816,
                    42.29907935
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Mayo Clinic, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92.466607460917,
                    44.0225389
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Office of Ramesh C. Gupta, MD, Fair Lawn, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74.1189924,
                    40.9210399
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "DJL Clinical Research, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.8430827,
                    35.2272086
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Health Research of Oklahoma, Oklahoma City, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97.5170536,
                    35.4729886
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.96246095144505,
                    40.44415295
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "West Tennessee Research Institute, Jackson, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88.8177418,
                    35.6144446
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Accurate Clinical Research, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.3676974,
                    29.7589382
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Texas Arthritis Research Center, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98.4951405,
                    29.4246002
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    151.18145903228103,
                    -33.88963645
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Southern Clinical Research Pty Ltd, Hobart, Tasmania, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    147.3281233,
                    -42.8825088
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Emeritus Research, Malvern, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    145.0350666,
                    -37.8576088
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis",
                "aff": "Department of Gastroenterology; Gulhane Military Medical Academy, Ankara, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT01378182",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 87, 45)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2011-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    32.8540482,
                    39.9207886
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B",
                "aff": "Cipto Mangunkusumo hospital, Jakarta, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04357600",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 101, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-05-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106.84674005186504,
                    -6.19720085
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Effectiveness of Adding Allogenic Stem Cells After Traditional Treatment of Osteochondral Lesions of the Talus",
                "aff": "Universidad de Chile Clinical Hospital, Santiago, Independencia, Chile",
                "url": "https://ClinicalTrials.gov/show/NCT03905824",
                "enrolled": 70,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 99, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2019-01-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -70.6665002964021,
                    -33.4041507
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Therapy for Chronic Kidney Disease",
                "aff": "Mayo Clinic Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04869761",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 68, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-09-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.44479406045171,
                    30.2604657
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Therapy for Chronic Kidney Disease",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04869761",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 68, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-09-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92.466607460917,
                    44.0225389
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells in Osteoarthritis",
                "aff": "Department of Orthopedics, M. S. Ramaiah Memorial Hospital, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01453738",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 71, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2011-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77.590082,
                    12.9767936
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells in Osteoarthritis",
                "aff": "Department of Orthopedics, Kasturba Medical College, Manipal, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01453738",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 71, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2011-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    74.78913348652112,
                    13.35373435
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells in Osteoarthritis",
                "aff": "Seth G. S. Medical College and KEM Hospital, Mumbai, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01453738",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 71, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2011-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    72.878176,
                    19.0785451
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells in Osteoarthritis",
                "aff": "Jehangir Hospital, Pune, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01453738",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 71, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2011-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    73.87665054967444,
                    18.53034355
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells in Osteoarthritis",
                "aff": "Department of Immunology Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India",
                "url": "https://ClinicalTrials.gov/show/NCT01453738",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 71, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2011-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    80.9346001,
                    26.8381
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas Patients With Crohn's Disease",
                "aff": "University of Malaya Medical Centre, Kuala Lumpur, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT05039411",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 93, 53)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2022-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101.65403830175345,
                    3.11256105
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease",
                "aff": "The University of Texas Health Science Center at Houston, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02611167",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 93, 45)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.3676974,
                    29.7589382
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis",
                "aff": "Hanyang university hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03174587",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 60, 25)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2017-05-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis",
                "aff": "China Medical University Hospital, Taichung, Non-US, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT05532943",
                "enrolled": 41,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 59, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2022-11-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120.9820179,
                    23.9739374
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With COVID-19",
                "aff": "China Medical University Hospital, Taichung, Non-US, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT05501418",
                "enrolled": 75,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2020-01-05",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120.9820179,
                    23.9739374
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation",
                "aff": "Indiana University, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02685098",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 102, 53)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.1769635756136,
                    39.77477735
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease",
                "aff": "Mayo Clinic Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05362786",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 63, 45)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.44479406045171,
                    30.2604657
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease",
                "aff": "Mayo Clinic Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05362786",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 63, 45)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92.466607460917,
                    44.0225389
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients",
                "aff": "Hanyang University Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04835883",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 105, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-08-26",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, Delhi, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 103, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77.2098719369258,
                    28.5643603
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Division of Peripheral Vascular and Endovascular Sciences, Medanta - The Medicity, Gurgaon, Haryana, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 103, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77.04034428844223,
                    28.43905715
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Vascular and Endovascular Surgery, M. S. Ramaiah Medical College and Hospitals, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 103, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77.590082,
                    12.9767936
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Peripheral Vascular Surgery, Sri Jayadeva Institute of Cardiovascular Sciences & Research, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 103, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77.590082,
                    12.9767936
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Surgery, KMC, Mangalore, Mangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 103, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    74.8480016484457,
                    12.85885905
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Vascular Surgery, Madras Medical College, Chennai, Tamil Nadu, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 103, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    80.27313464478527,
                    13.079761
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Vascular Surgery, Sri Ramchandra Medical College, Chennai, Tamil Nadu, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 103, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    80.270186,
                    13.0836939
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Vascular Surgery, Stanley Medical College, Chennai, Tamil Nadu, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 103, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    80.28716805763241,
                    13.10609125
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Vascular Surgery, AMRI Hospital, Kolkata, West Bengal, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 103, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    88.3676076,
                    22.5125412
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Nightingale Hospital, Kolkata, West Bengal, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 103, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    88.3515425,
                    22.546022
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure",
                "aff": "MedStar Washington Hospital Center, Washington, District of Columbia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02467387",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 87, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.0365427,
                    38.8950368
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure",
                "aff": "Emory University Hospital, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02467387",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 87, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.32208292907711,
                    33.792151000000004
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure",
                "aff": "Northwestern University Centers for Heart Failure Therapy, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02467387",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 87, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.6244212,
                    41.8755616
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure",
                "aff": "Stony Brook Heart Institute, Stony Brook, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02467387",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 87, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.140943,
                    40.9256538
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure",
                "aff": "Hospital of the University of Pennsylvania, Heart Failure and Transplant Program, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02467387",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 87, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.1635262,
                    39.9527237
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia",
                "aff": "The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT04255147",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 91, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2022-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.64648499814479,
                    45.40180795
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Myocardial Infarction",
                "aff": "China Medical University Hospital, Taichung, Non-US, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT04056819",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 60, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-05-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120.9820179,
                    23.9739374
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Osteoarthritis",
                "aff": "Pantai Cheras Medical Centre, Kuala Lumpur, Federal territory, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT01448434",
                "enrolled": 72,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 64, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2011-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101.6937436,
                    3.1396189
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Osteoarthritis",
                "aff": "Serdang Hospital, Kuala Lumpur, Selangor, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT01448434",
                "enrolled": 72,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 64, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2011-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101.69325937891328,
                    2.748372
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Osteoarthritis",
                "aff": "KPJ Ampang Puteri Specialist Hospital, Kuala Lumpur, Selangor, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT01448434",
                "enrolled": 72,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 64, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2011-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101.69325937891328,
                    2.748372
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Osteoarthritis",
                "aff": "Selayang Hospital, Kuala Lumpur, Selangor, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT01448434",
                "enrolled": 72,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 64, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2011-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101.69325937891328,
                    2.748372
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)",
                "aff": "Asthma and Allergy Consultants, Wichita, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02235844",
                "enrolled": 1,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 99, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12989,
                "paneLabel": "pane12989",
                "start": "2014-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97.3375448,
                    37.6922361
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients",
                "aff": "Dr. Moewardi General Hospital, Surakarta, Central Java, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05132972",
                "enrolled": 42,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 84, 60)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    110.828448,
                    -7.5692489
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients",
                "aff": "Dr. Hasan Sadikin, Bandung, West Java, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05132972",
                "enrolled": 42,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 84, 60)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    107.6049539,
                    -6.9344694
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients",
                "aff": "Dr. Sardjito General Hospital, Yogyakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05132972",
                "enrolled": 42,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 84, 60)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    110.36722565020224,
                    -7.977838399999999
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Wharton\u00b4s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes",
                "aff": "Karolinska Trial Alliance, Fas 1 enheten, Karolinska Universitetssjukhuset Huddinge, Stockholm, Sweden",
                "url": "https://ClinicalTrials.gov/show/NCT03406585",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 91, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-10-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    17.935005691942855,
                    59.22125005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Heart Failure Using Human Umbilical Cord Mesenchymal Stem Cells(hUC-MSC)",
                "aff": "Shanghai East Hospital, Shanghai Tongji University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04939077",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 89, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2019-10-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4452993,
                    31.4015684
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD).",
                "aff": "Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04995081",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 68, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2021-07-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.6349463,
                    29.6196787
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro",
                "aff": "University Clinical Hospital of Salamanca, Salamanca, Salamanca/Castilla Le\u00f3n, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02104440",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 104, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2013-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5.5918712,
                    42.6102981
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB",
                "aff": "GangnamSeverance Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04520022",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 67, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2016-09-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell and Conditioned Medium for Cerebral Palsy",
                "aff": "Indonesian National Brain Center, Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04314687",
                "enrolled": 78,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 99, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2021-09-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106.827183,
                    -6.1753942
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy of Allogeneic UCMSCs for Treating Large Defects Knee Injury",
                "aff": "Hospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia (HCTM-UKM), Bandar Tun Razak, Wilayah Persekutuan Kuala Lumpur, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT05016011",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 67, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2020-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101.71246244415164,
                    3.0896887
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic MSC Treatment for Pulmonary Emphysema",
                "aff": "Department of Pulmonology, Leiden University Medical Center, Leiden, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT04918706",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 81, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2019-06-25",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4.4908843,
                    52.1594747
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients",
                "aff": "Renmin Hospital of Wuhan University (East Campus), Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT04336254",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 66, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-05-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114.2999353,
                    30.5951051
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients",
                "aff": "Site 550: University of Hassanudin/ Dr. Wahidin Sudirohusodo Hospital, Makassar, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04535856",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 83, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-10-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    119.4124282,
                    -5.1342962
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Pericardial Matrix With Mesenchymal Stem Cells for the Treatment of Patients With Infarcted Myocardial Tissue",
                "aff": "Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT03798353",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 87, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-05-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2.2381723732976044,
                    41.4810542
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Chronic Wounds in Diabetic Foot Syndrome With Allogeneic Adipose Derived Mesenchymal Stem Cells",
                "aff": "Medical University of Warsaw, Department of Diabetology and Internal Diseases, Warsaw, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03865394",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 64, 49)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2019-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    21.0067249,
                    52.2319581
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of UCB and MSCs in Children With CP: ACCeNT-CP",
                "aff": "Duke University Medical Center, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03473301",
                "enrolled": 91,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 59, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2018-04-10",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.93676230303336,
                    36.0095073
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Use of Mesenchymal Stem Cells (MSCs) Differentiated Into Neural Stem Cells (NSCs) in People With Parkinson's (PD).",
                "aff": "Cell Therapy Center, University of Jordan, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT03684122",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 97, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35.87338209486857,
                    32.013409249999995
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells",
                "aff": "McGill University Health Centre, Montreal, Quebec, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT04869397",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 58, 36)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-06-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.5999506480536,
                    45.47401605
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized Double-Blind Phase 2 Study of Allogeneic HB-adMSCs for the Treatment of Chronic Post-COVID-19 Syndrome",
                "aff": "Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05126563",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 105, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2022-01-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.6349463,
                    29.6196787
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transplantation of Allogeneic MSC in Patients With Pulp Necrosis and Chronic Apical Periodontitis",
                "aff": "Unidad de Terapia Celular del Instituto de Investigaciones Cient\u00edficas, San Antonio de los Altos, Miranda, Venezuela",
                "url": "https://ClinicalTrials.gov/show/NCT04545307",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 64, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2019-10-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -66.9665409,
                    10.3751347
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD",
                "aff": "University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05333029",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 64, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2022-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.6936813,
                    41.4996562
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism",
                "aff": "Stem Cell Institute, Panama City, Panama",
                "url": "https://ClinicalTrials.gov/show/NCT02192749",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 105, 15)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.5341802,
                    8.9714493
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic BM-MSCs in Patients With Lumbar Facet Arthropathy",
                "aff": "Mayo Clinic in Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04410731",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 62, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-04-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.44858105666715,
                    30.2588308
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Soffer Health Institute, Aventura, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 87, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.1392121,
                    25.9564812
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Clinical Research of South Florida, Coral Gables, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 87, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.2683838,
                    25.72149
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Clinical Physiology Associates, Fort Myers, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 87, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.8723084,
                    26.640628
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Panax Clinical Research, Miami Lakes, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 87, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.3086619,
                    25.9087056
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Miami VA Healthcare System, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 87, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Vista Health Research, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 87, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Advanced Research for Health Improvement, LLC, Naples, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 87, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.80231377307933,
                    26.21044935
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Therapy to Improve Burn Wound Healing",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02104713",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 107, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2014-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.27870688083459,
                    25.71727245
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis",
                "aff": "Cleveland Clinic, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04548583",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 94, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-10-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.61981946090904,
                    41.50217195
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease",
                "aff": "Vinmec International Hospital Times City, H\u00e0 N\u1ed9i, Hanoi, Vietnam",
                "url": "https://ClinicalTrials.gov/show/NCT04433104",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 89, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2020-06-09",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    105.8544441,
                    21.0294498
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC)",
                "aff": "Cleveland Clinic, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04543994",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 57, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-10-10",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.61981946090904,
                    41.50217195
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "Clinical Research of South Florida, Coral Gables, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 89, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2016-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.2683838,
                    25.72149
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "Clinical Physiology Associates, Fort Myers, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 89, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2016-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.8723084,
                    26.640628
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 89, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2016-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.27870688083459,
                    25.71727245
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "Vista Health Research, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 89, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2016-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "Johns Hopkins University, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 89, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2016-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.62185357858337,
                    39.33020225
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "Optimal Research LLC, Rockville, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 89, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2016-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.1516844,
                    39.0817985
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Alzheimer's Disease Stem Cells Multiple Infusions",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04040348",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 66, 55)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2019-09-08",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.27870688083459,
                    25.71727245
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS",
                "aff": "Miami Baptist Hospital, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04494386",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 101, 25)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2020-07-23",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.33858857540258,
                    25.68511695
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS",
                "aff": "Sanford Research, Sioux Falls, South Dakota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04494386",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 101, 25)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2020-07-23",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.7307737,
                    43.5488256
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "St. Francis Hospital, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 59, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.1583502,
                    39.7683331
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "Kansas City Cancer Centers - BMT, Kansas City, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 59, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94.5781416,
                    39.100105
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "The Cancer Center at Hackensack University, Hackensack, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 59, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74.0410865,
                    40.8871438
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "Roswell Park Cancer Institute, Buffalo, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 59, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.8783922,
                    42.8867166
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "Mt. Sinai Hospital, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 59, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Rochester, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 59, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.6307297,
                    43.1226985
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "New York Medical College, Valhalla, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 59, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.7751326,
                    41.0748189
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "MD Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 59, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.39782993506569,
                    29.7076703
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "Medical College of Wisconsin, FEC, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 59, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.922497,
                    43.0349931
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)",
                "aff": "Emory University/Childen's Healthcare of Atlanta, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03525418",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 92, 45)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-02-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.3902644,
                    33.7489924
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)",
                "aff": "University of Maryland Medical Center, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03525418",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 92, 45)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-02-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.62439437177966,
                    39.28827365
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)",
                "aff": "Johns Hopkins University Hospital, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03525418",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 92, 45)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-02-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.610759,
                    39.2908816
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)",
                "aff": "Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03525418",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 92, 45)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-02-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.50228846584608,
                    39.14084475
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)",
                "aff": "University of Utah/Heart Center-Primary Children's Hospital, Salt Lake City, Utah, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03525418",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 92, 45)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-02-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111.8867975,
                    40.7596198
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa",
                "aff": "Jakarta Eye Center Hospital, Jakarta, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04315025",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 70, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2018-09-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106.8277658,
                    -6.1875613
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa",
                "aff": "Sardjito Hospital, Yogyakarta, Special Region, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04315025",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 70, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2018-09-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    110.364917,
                    -7.8011945
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Ossium Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in the Setting of Crohn's Disease",
                "aff": "Cleveland Clinic, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05075811",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 65, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.61981946090904,
                    41.50217195
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Knee Osteoarthritis",
                "aff": "Clinica Universidad de los Andes, Santiago, Chile",
                "url": "https://ClinicalTrials.gov/show/NCT02580695",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 76, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -70.50308926300528,
                    -33.40768165
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy",
                "aff": "Yan'an Hospital of Kunming City, Kunming, China",
                "url": "https://ClinicalTrials.gov/show/NCT04125329",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 57, 22)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    102.8324209,
                    24.8843019
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord Mesenchymal Stem Cells For the Treatment of Lumbar Disc Degeneration Disease",
                "aff": "Shanghai General Hospital, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04414592",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 94, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.22177867067153,
                    31.0427014
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord Mesenchymal Stem Cells For the Treatment of Lumbar Disc Degeneration Disease",
                "aff": "Shanghai General Hospital, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04414592",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 94, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.22177867067153,
                    31.0427014
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)",
                "aff": "Obstetrics and Gynecology Hospital of Fudan University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT03645525",
                "enrolled": 180,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 64, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2019-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4452993,
                    31.4015684
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)",
                "aff": "Children's Hospital of Fudan University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT03645525",
                "enrolled": 180,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 64, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2019-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4452993,
                    31.4015684
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)",
                "aff": "Shanghai First Maternity and Infant Hospital, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT03645525",
                "enrolled": 180,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 64, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2019-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4452993,
                    31.4015684
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency",
                "aff": "Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam",
                "url": "https://ClinicalTrials.gov/show/NCT05345418",
                "enrolled": 158,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 94, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2022-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    105.8544441,
                    21.0294498
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Safety/Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife\u00ae-LDP) for Lumbar Discogenic Pain",
                "aff": "Xuanwu Hospital Capital Medical University, Beijing, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT04104412",
                "enrolled": 242,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 77, 47)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2019-01-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116.3912757,
                    39.906217
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1)",
                "aff": "Beijing 302 Hospital, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT05227846",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 88, 35)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2022-03-22",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116.3912757,
                    39.906217
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Repeated Subarachnoid Administrations of hUC-MSCs in Treating SCI",
                "aff": "The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT02481440",
                "enrolled": 102,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 93, 47)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2018-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113.33571464111392,
                    23.13654195
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis",
                "aff": "Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam",
                "url": "https://ClinicalTrials.gov/show/NCT05331872",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 80, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    105.8544441,
                    21.0294498
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease",
                "aff": "Li Yu, Shenzhen, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT05152160",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 63, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2021-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114.0545429,
                    22.5445741
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "hUC Mesenchymal Stem Cells (19#iSCLife\u00ae-CSD) Therapy for Patients With Healing Poor After Uterus Injury",
                "aff": "Xiangya Hospital Central South University, Changsha, Hunan, China",
                "url": "https://ClinicalTrials.gov/show/NCT03386708",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 102, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113.2384362,
                    28.1450774
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19",
                "aff": "Instituto de Medicina Regenerativa, Tijuana, Baja California, Mexico",
                "url": "https://ClinicalTrials.gov/show/NCT04456361",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 69, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-04-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -116.964662,
                    32.5010188
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19",
                "aff": "BioXcellerator, Medellin, Antioquia-CO, Colombia",
                "url": "https://ClinicalTrials.gov/show/NCT04390152",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 81, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2020-01-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.573553,
                    6.2443382
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19",
                "aff": "Clinical Somer, Rionegro, Antioquia, Colombia",
                "url": "https://ClinicalTrials.gov/show/NCT04390152",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 81, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2020-01-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.3741691,
                    6.1536166
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus",
                "aff": "Shanghai East Hospital, Shanghai Tongji University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04441658",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 77, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-10",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4452993,
                    31.4015684
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)",
                "aff": "Shanghai Sixth People's Hospital, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT05468502",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 63, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.41788315057596,
                    31.18040725
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord Mesenchymal Stem Cell Transplantation in Articular Cartilage Defect",
                "aff": "The Fifth Affiliated Hospital Immunotherapy center, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT02291926",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 92, 47)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113.2592945,
                    23.1301964
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multi-intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Heart Failure With Reduced Ejection Fraction\uff08PRIME-HFrEF Study\uff09",
                "aff": "Heart Failure Department, East Hospital Affiliated to Tongji University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04992832",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 64, 28)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-07-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4452993,
                    31.4015684
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury",
                "aff": "Shanghai East Hospital, Shanghai Tongji University, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04996966",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 91, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4692071,
                    31.2322758
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u2122 Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease",
                "aff": "Osiris Clinical Site, Baton Rouge, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00294112",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 62, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2006-03-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91.1391153,
                    30.4507936
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u2122 Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease",
                "aff": "Osiris Clinical Site, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00294112",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 62, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2006-03-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.8430827,
                    35.2272086
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u2122 Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease",
                "aff": "Osiris Clinical Site, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00294112",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 62, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2006-03-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.6243098,
                    40.3693889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u2122 Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease",
                "aff": "Osiris Clinical Site, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00294112",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 62, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2006-03-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.43428,
                    37.5385087
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis",
                "aff": "Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT03745417",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 69, 25)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2021-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113.2592945,
                    23.1301964
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis",
                "aff": "Stem Cell Institute, Panama City, Panama",
                "url": "https://ClinicalTrials.gov/show/NCT02034188",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 58, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.5341802,
                    8.9714493
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Evaluation of the Effect of Mesenchymal Stem Cells on the Immune System of Patients With ALS",
                "aff": "JST sp. z o.o., Cz\u0119stochowa, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT04651855",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 85, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-11-02",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    19.134422,
                    52.215933
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate and Severe Crohn's Disease",
                "aff": "Shanghai East Hospital, Shanghai, Pudong New Area, China",
                "url": "https://ClinicalTrials.gov/show/NCT05262829",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 100, 28)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2022-02-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.5919989893762,
                    31.24075985
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "hUC Mesenchymal Stem Cells (19#iSCLife\u00ae-UT) Therapy for Patients With Thin Endometrial Infertility",
                "aff": "Xiangya Hospital Central South University, Changsha, Hunan, China",
                "url": "https://ClinicalTrials.gov/show/NCT05495711",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 59, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113.2384362,
                    28.1450774
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells to Treat Type 2 Diabetes",
                "aff": "Chinese PLA General Hospital, Beijing, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT02302599",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 63, 30)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2013-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116.3912757,
                    39.906217
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke",
                "aff": "Department of Neurology, General Hospital of Northern Theater Command, Shenyang, China",
                "url": "https://ClinicalTrials.gov/show/NCT04811651",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-03-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    123.458674,
                    41.6749893
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty",
                "aff": "Shanghai East Hospital, Shanghai Tongji University, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04314011",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 105, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4692071,
                    31.2322758
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study on Radiation-induced Pulmonary Fibrosis Treated With Clinical Grade Umbilical Cord Mesenchymal Stem Cells",
                "aff": "First Affiliated Hospital of the Third Military University, PLA (Southwest Hospital), Chongqing, Chongqing, China",
                "url": "https://ClinicalTrials.gov/show/NCT02277145",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 105, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2014-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106.5478767,
                    29.5647398
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study on Pneumoconiosis Treated With Whole-lung Lavage Combined With Mesenchymal Stem Cells",
                "aff": "First Affiliated Hospital of the Third Military University, PLA (Southwest Hospital), Chongqing, Chongqing, China",
                "url": "https://ClinicalTrials.gov/show/NCT02668068",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 59, 42)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2016-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106.5478767,
                    29.5647398
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study on Pneumoconiosis Treated With Whole-lung Lavage Combined With Mesenchymal Stem Cells",
                "aff": "Nanjing Chest Hosptial, Nanjing, Jiangsu, China",
                "url": "https://ClinicalTrials.gov/show/NCT02668068",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 59, 42)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2016-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    118.7915079,
                    32.0615652
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Sub-Acute Stroke Infarct",
                "aff": "Gatot Soebroto Hospital, Jakarta Pusat, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05008588",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 85, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2021-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106.83711442228916,
                    -6.1766593
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Sub-Acute Stroke Infarct",
                "aff": "PT Prodia StemCell Indonesia, Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05008588",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 85, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2021-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106.827183,
                    -6.1753942
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem Cells",
                "aff": "Ankara University Biotechnology Institute, Ankara, T\u00fcrkiye, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT04224207",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 105, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2019-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    34.9249653,
                    38.9597594
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem Cells",
                "aff": "Umut Arslan, Ankara, T\u00fcrkiye, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT04224207",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 105, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2019-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    34.9249653,
                    38.9597594
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis",
                "aff": "Beijing 302 Hospital, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT03945487",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 104, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2019-05-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116.3912757,
                    39.906217
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients",
                "aff": "Gang Li, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04093336",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 89, 30)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2019-01-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.3989967,
                    31.2748685
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Alabama at Birmingham, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.80604756076488,
                    33.5016153
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Arizona Cancer Center, Tucson, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -110.94208772039823,
                    32.2766429
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "City of Hope, Duarte, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.97324485,
                    34.1276438
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Univeristy of California San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.419906,
                    37.7790262
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Yale New Haven Hospital, New Haven, Connecticut, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72.93559409819855,
                    41.3046035
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.27870688083459,
                    25.71727245
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "All Children's Hospital, Saint Petersburg, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.64059775080256,
                    27.76496205
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Emory University, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.32778960627682,
                    33.795867650000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Northside Hospital, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.35450682100918,
                    33.9102901
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Northwestern Center for Clinical Research, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.6244212,
                    41.8755616
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.66910060446992,
                    41.87352605
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Illinois - Chicago, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.60084387193544,
                    41.79139685
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Indiana Blood and Bone Marrow Transplant Center, Beech Grove, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.0894158,
                    39.7221906
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Univeristy of Iowa Hospitals and Clinics, Iowa City, Iowa, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91.5299106,
                    41.6612561
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Kansas Medical Center, Kansas City, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94.60953952536904,
                    39.05699635
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Louisville, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85.75770751081866,
                    38.21332235
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Louisiana State University, Shreveport, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93.70247014954433,
                    32.4297329
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Maryland/Greenbaum, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.610759,
                    39.2908816
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Tufts-New England Medical Center, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.060511,
                    42.3554334
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.10970567673255,
                    42.33837185
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Dana-Farber Cancer Institute, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.10769331557015,
                    42.33762635
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Karmanos/Wayne State University, Detroit, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.0466403,
                    42.3315509
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Mayo Clinic Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92.466607460917,
                    44.0225389
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Univeristy of Mississippi Medical Center, Jackson, Mississippi, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.1983063,
                    32.3086744
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Nebraska, Omaha, Nebraska, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.0104763,
                    41.257793250000006
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Hackensack University Medical Center, Hackensack, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74.05594087673457,
                    40.8837051
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Roswell Park, Buffalo, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.86568071180923,
                    42.898619800000006
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "New York Presbyterian Hospital, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Mount Sinai Medical Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Columbia University/New York Presbyterian Hospital, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Rochester, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.6307297,
                    43.1226985
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "New York Medical College, Valhalla, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.7751326,
                    41.0748189
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Duke University, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.94422972195878,
                    36.00015569999999
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Wake Forest Univeristy School of Medicine, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.2440518,
                    36.0998131
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Oregon Health and Science University, Portland, Oregon, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.674194,
                    45.5202471
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Penn State Hershey Medical Center, Hershey, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.67321279234645,
                    40.2653862
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Western Pennsylvania Cancer Institute, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.6243098,
                    40.3693889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.94714193501349,
                    32.7842965
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Texas Cancer Center at Medical City, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.7968559,
                    32.7762719
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Baylor University, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.78199034999996,
                    32.7865443
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Univeristy of Texas Southwestern Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.7968559,
                    32.7762719
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "MD Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.39782993506569,
                    29.7076703
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Texas Research Center, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98.58294226252109,
                    29.51447155
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Virginia Commonwealth/Massey Cancer Center, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.43428,
                    37.5385087
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Fred Hutchinson Cancer Research Center, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.33067301841714,
                    47.6277525
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Wisconsin Madison, Madison, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.43095871991434,
                    43.080274450000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Medical College of Wisconsin, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88.02245316747553,
                    43.04386705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Brisbane Hospital, Herston, Queensland, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    153.02681090546656,
                    -27.4477301
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Melbourne Hospital, Parkville, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144.9559783,
                    -37.7994515
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Perth Hospital, Perth, Western Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    115.86593154993494,
                    -31.95323205
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Co-Medica Research Network, Calgary, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -114.065465,
                    51.0460954
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "British Columbia's Children's Hospital, Vancouver, British Columbia, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -123.113952,
                    49.2608724
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Cancer Care Manitoba, Winnipeg, Manitoba, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97.15878771446602,
                    49.90309155
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -63.5859487,
                    44.648618
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Hamilton Health Sciences Centre, Hamilton, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.8728583,
                    43.2560802
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "London Health Sciences Centre- Westminster Campus, London, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.243372,
                    42.9832406
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Ottawa Hospital, Ottawa, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.72059219183689,
                    45.39147405
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Toronto General Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.38815803478147,
                    43.6585876
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Princess Margaret Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.39064248533157,
                    43.65816355
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.56227634786634,
                    45.57753825
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Hopital Enfant-Jesus, Quebec, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.22789382663336,
                    46.8386952
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Hopital du Saint-Sacrement, Quebec, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.24626006730523,
                    46.79977065
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Universia degli Studi di Pesaro, Pesaro, PU, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12.9131228,
                    43.9098114
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "IRCCS Policlinico San Matteo, Pavia, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9.137825082826026,
                    45.03685465
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Kantonsspital Basel, Basel, Switzerland",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7.503841,
                    47.424635
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Barts & London School of Medicine, London, England, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -0.0992899692337679,
                    51.522169000000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "John Radcliffe Hospital, Headington, Oxford, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1.2180558792629186,
                    51.76413405
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Bristol Royal Hospital for Children, Bristol, UK, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -2.9937826923778914,
                    51.136471400000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Glasgow Royal Infirmary, Glasgow, UK, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4.2488787,
                    55.8609825
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Leeds General Infirmary, Leeds, UK, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 65, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1.6014905,
                    53.7460006
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia",
                "aff": "Yunfei Chen, Tianjin, Tianjin, China",
                "url": "https://ClinicalTrials.gov/show/NCT04014166",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 92, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-10-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    117.1951073,
                    39.0856735
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT00823316",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 60, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2008-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of Umbilical Cord Mesenchymal Stem Cells Combined With Collagen Scaffold in the Treatment of Thin Endometrium",
                "aff": "Sir Run Run Shaw hopital,School of medicine,Zhejiang University, Hangzhou, China",
                "url": "https://ClinicalTrials.gov/show/NCT03724617",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 99, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2018-09-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120.07879105081204,
                    30.2984361
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of UC-MSC Transfusion for ACLF Patients",
                "aff": "Ren Ji Hospital, School of Medicine, Shanghai Jiao TongUniversity,, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04822922",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 93, 30)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-08-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4452993,
                    31.4015684
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome",
                "aff": "Nancy University Hospital, Vand\u0153uvre-l\u00e8s-Nancy, France",
                "url": "https://ClinicalTrials.gov/show/NCT04625738",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 66, 25)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-10-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    1.8883335,
                    46.603354
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of Mild to Moderate ED",
                "aff": "Z Urology, Coral Springs, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02398370",
                "enrolled": 8,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 66, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.2706044,
                    26.271192
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PD",
                "aff": "Z Urology, Coral Springs, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02395029",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 93, 28)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2013-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.2706044,
                    26.271192
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars",
                "aff": "Maternal and Child Health Hospital of Foshan, Foshan, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT03181087",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 99, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2021-11-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113.1159558,
                    23.0239788
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants",
                "aff": "National Chen-Kung University Hospital, Tainan City, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT03631420",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 72, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-09-26",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120.2124235,
                    22.9914751
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSCs for Prevention of MI-induced HF",
                "aff": "Al-Zahra Heart Hospital, Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05043610",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 92, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2021-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    54.5643516,
                    32.6475314
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSCs for Prevention of MI-induced HF",
                "aff": "Faghihi Hospital, Shiraz, Fars, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05043610",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 92, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2021-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    54.5643516,
                    32.6475314
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSCs for Prevention of MI-induced HF",
                "aff": "Namazee Hospital, Shiraz, Fars, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05043610",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 92, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2021-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    54.5643516,
                    32.6475314
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis",
                "aff": "The Prince Charles Hospital, Brisbane, Queensland, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01385644",
                "enrolled": 8,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 103, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2010-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    153.0230853672162,
                    -27.388817000000003
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Safety and The Efficacy Evaluation of NEUROSTEM\u00ae-AD in Patients With Alzheimer's Disease",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01297218",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 63, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2011-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of PNEUMOSTEM\u00ae in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US Study",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02381366",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 53)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2015-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.66910060446992,
                    41.87352605
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of Alabama, Division of Endocrinology & Metabolism, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 70, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.8024326,
                    33.5206824
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Scripps Whittier Diabetes Institute, La Jolla, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 70, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.2740777,
                    32.8401623
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Stanford University, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 70, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.16936535498309,
                    37.43131385
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of Florida, Gainesville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 70, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.34901329340119,
                    29.6328784
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Diabetes Research Institute, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 70, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.21148042151425,
                    25.78908785
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of Kentucky, Lexington, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 70, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.5048374161113,
                    38.027038
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of Minnesota, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 70, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93.17945580218505,
                    44.9863392
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Desert Endocrinology CRC, Henderson, Nevada, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 70, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -114.9826194,
                    36.0301134
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Nevada Alliance Against Diabetes, Las Vegas, Nevada, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 70, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.148516,
                    36.1672559
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of North Carolina Diabetes Care Center, Chapel Hill, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 70, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.05578,
                    35.9131542
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "American Health Research, Inc., Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 70, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.98533442909053,
                    35.144928300000004
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "The Lindner Clinical Trial Center, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 70, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.5124602,
                    39.1014537
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Providence Health Partners - Center for Clinical Research, Dayton, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 70, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.1916069,
                    39.7589478
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Cumberland Valley Endocrinology, Carlisle, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 70, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.1890783,
                    40.201499
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "AM Diabetes & Endocrinology Center, Bartlett, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 70, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.8739753,
                    35.2045329
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "The University of Texas Southwestern Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 70, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.7968559,
                    32.7762719
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Optimum Clinical Research, Inc., Salt Lake City, Utah, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 70, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111.95661302627656,
                    40.748542400000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "The Strelitz Diabetes Center, Eastern VA Medical School, Norfolk, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 70, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.2602336,
                    36.8968052
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of Wisconsin Health- West Clinic, Madison, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 70, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.3837613,
                    43.074761
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Clinical and Transitional Science Institute, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 70, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.922497,
                    43.0349931
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Application of hUC-MSCs in Treating Acute Lung Injury: a Single Center Prospective Clinical Research",
                "aff": "SAHZU, Hanzhou, Zhejiang, China",
                "url": "https://ClinicalTrials.gov/show/NCT04951882",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 82, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2021-06-09",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120.37342882420911,
                    30.30806645
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Exploratory Efficacy Study of NEUROSTEM\u00ae in Subjects Who Control Group of NEUROSTEM\u00ae",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04954534",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 90, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2021-07-12",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars",
                "aff": "Maternal and Child Health Hospital of Foshan, Foshan, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT02968459",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 105, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2021-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113.1159558,
                    23.0239788
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Southern California University Hospital, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.20188823929676,
                    34.0627257
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of California, San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.45825681806237,
                    37.7627257
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Western States Clinical Research, Wheat Ridge, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -105.0772063,
                    39.766098
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Clinical Research of West Florida, Clearwater, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.8001026,
                    27.9658533
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Borland-Groover Clinic, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.655651,
                    30.3321838
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Shafran Gastroenterology Center, Winter Park, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.3510264,
                    28.5977707
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Atlanta Gastroenterology Associates, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.3902644,
                    33.7489924
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Chicago Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.6244212,
                    41.8755616
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Carle Clinic Association, Urbana, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88.207301,
                    40.1117174
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Indiana University Medical Center, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.16382215911352,
                    39.78755735
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Cotton-O'Neil Clinical Research Center, Topeka, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.677556,
                    39.049011
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Kentucky Hospital, Lexington, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.5082097,
                    38.0286002
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Louisville Hospital, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85.74506887135223,
                    38.2483107
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Gulf Coast Research, Baton Rouge, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91.1391153,
                    30.4507936
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Maryland, Baltimore, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.62630185349286,
                    39.289447800000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "National Institutes of Health, Bethesda, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.1040039652674,
                    39.00001425
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Chevy Chase Clinical Research, Chevy Chase, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.0849245,
                    38.9813699
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.06875296664998,
                    42.36286045
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Brigham and Womens Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.060511,
                    42.3554334
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Clinical Pharmacology Study Group, Worcester, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.8018877,
                    42.2625621
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Center for Clinical Studies, Dearborn, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.1763145,
                    42.3222599
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Center for Digestive Health, Troy, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.1499304,
                    42.6055893
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Minnesota Hospital, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93.23144466768856,
                    44.97101265
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "St Louis Center for Clinical Studies, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.2428756,
                    38.6319657
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72.27010183310576,
                    43.67568425
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Weill Cornell Medical College, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.9549121,
                    40.7647523
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Mount Sinai School of Medicine, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Rochester Institute for Digestive Diseases, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.615214,
                    43.157285
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Rochester General Hospital, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.5882888540516,
                    43.1920427
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University Hospital and Medical Center, Stony Brook, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.140943,
                    40.9256538
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Charlotte Gastroenterology and Hepatology, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.8430827,
                    35.2272086
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Pinehurst Medical Clinic, Pinehurst, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.4679317,
                    35.1946235
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Wake Forest University, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.2781152,
                    36.134335
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Gastroenterology United of Tulsa, Tulsa, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.9927436,
                    36.1563122
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Options Health Research, Tulsa, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.9927436,
                    36.1563122
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Allegheney Center for Digestive Health, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.6243098,
                    40.3693889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.96246095144505,
                    40.44415295
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Gastroenterology Center of the Midsouth, Germantown, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.8100858,
                    35.0867577
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Nashville GI Specialists, Nashville, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.7742984,
                    36.1622767
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Vanderbilt University Medical Center, Nashville, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.80163418092431,
                    36.14092375
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Baylor University Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.78199034999996,
                    32.7865443
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Texas Medical Branch, Galveston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94.77627329985782,
                    29.31201835
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Texas Health Science Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.4031517,
                    29.7029914
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Vermont, Burlington, Vermont, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.19414679705882,
                    44.4737365
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Digestive and Liver Disease Specialists, Norfolk, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.2602336,
                    36.8968052
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "McGuire Research Institute, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.43428,
                    37.5385087
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Seattle Gastroenterology Associates, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.330062,
                    47.6038321
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Royal Adelaide Hospital, Adelaide, South Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    138.58717276889342,
                    -34.9205767
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Royal Melbourne Hospital, Melbourne, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144.9564192,
                    -37.7994568
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Calgary, Calgary, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -114.1283072,
                    51.0783651
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Alberta Hospital, Edmonton, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -113.52319456480116,
                    53.5206381
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Health Science Centre, Winnipeg, Manitoba, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97.16277302533985,
                    49.90816975
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "London Health Sciences Centre, London, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.243372,
                    42.9832406
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Mount Sinai Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.39033976650668,
                    43.657443650000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Otago, Christchurch, New Zealand",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    172.6318208,
                    -43.5348592
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Waikato Hospital, Hamilton, New Zealand",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    175.28295759033938,
                    -37.80537155
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial",
                "aff": "UC Davis Health, Sacramento, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04652908",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 96, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2021-06-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -121.493895,
                    38.5810606
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Use of UC-MSCs for COVID-19 Patients",
                "aff": "Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04355728",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 76, 22)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-04-25",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Evaluation of PNEUMOSTEM\u00ae Treatment in Premature Infants With Bronchopulmonary Dysplasia",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01297205",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 91, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2010-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for the Treatment of COVID-19",
                "aff": "Southern California Hospital at Culver City / Southern California Hospital at Hollywood, Culver City, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04573270",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 89, 45)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2020-04-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.396466,
                    34.0211224
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Advanced Clinical Research Institute, Anaheim, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.911732,
                    33.8347516
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Veteran's Administration Medical Center (does not require vet status), Long Beach, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.191604,
                    33.7690164
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Southern California University Hospital, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.20188823929676,
                    34.0627257
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of California, San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.45825681806237,
                    37.7627257
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Western States Clinical Research, Wheat Ridge, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -105.0772063,
                    39.766098
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Gastroenterology Center of Connecticut, Hamden, Connecticut, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72.8968716,
                    41.3959287
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Clinical Research of West Florida, Clearwater, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.8001026,
                    27.9658533
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Borland-Groover Clinic, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.655651,
                    30.3321838
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Venture Research Institute, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Shafran Gastroenterology Center, Winter Park, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.3510264,
                    28.5977707
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Atlanta Gastroenterology Associates, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.3902644,
                    33.7489924
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Chicago Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.6244212,
                    41.8755616
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Carle Clinic Association, Urbana, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88.207301,
                    40.1117174
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Indiana University Medical Center, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.16382215911352,
                    39.78755735
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Cotton-O'Neil Clinical Research Center, Topeka, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.677556,
                    39.049011
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Kentucky Hospital, Lexington, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.5082097,
                    38.0286002
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Louisville Hospital, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85.74506887135223,
                    38.2483107
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Gulf Coast Research, Baton Rouge, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91.1391153,
                    30.4507936
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "National Institutes of Health, Bethesda, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.1040039652674,
                    39.00001425
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Metropolitan Gastroenterology Group, Chevy Chase, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.0849245,
                    38.9813699
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.06875296664998,
                    42.36286045
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Brigham and Womens Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.060511,
                    42.3554334
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Clinical Pharmacology Study Group, Worcester, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.8018877,
                    42.2625621
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Center for Clinical Studies, Dearborn, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.1763145,
                    42.3222599
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Center for Digestive Health, Troy, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.1499304,
                    42.6055893
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Minnesota Hospital, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93.23144466768856,
                    44.97101265
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "St Louis Center for Clinical Studies, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.2428756,
                    38.6319657
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72.27010183310576,
                    43.67568425
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Gastroenterology Research Associates, Cedar Knolls, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74.448765,
                    40.8220442
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Holy Name Hospital, Teaneck, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74.01060090485666,
                    40.8830725
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Weill Cornell Medical College, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.9549121,
                    40.7647523
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Mount Sinai School of Medicine, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Rochester Institute for Digestive Diseases, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.615214,
                    43.157285
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Rochester General Hospital, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.5882888540516,
                    43.1920427
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University Hospital and Medical Center, Stony Brook, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.140943,
                    40.9256538
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Charlotte Gastroenterology and Hepatology, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.8430827,
                    35.2272086
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Pinehurst Medical Clinic, Pinehurst, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.4679317,
                    35.1946235
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Wake Forest University, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.2781152,
                    36.134335
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Dayton Science Institute, Dayton, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.1916069,
                    39.7589478
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Gastroenterology United of Tulsa, Tulsa, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.9927436,
                    36.1563122
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Options Health Research, Tulsa, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.9927436,
                    36.1563122
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Allegheney Center for Digestive Health, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.6243098,
                    40.3693889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.96246095144505,
                    40.44415295
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Gastroenterology Center of the Midsouth, Germantown, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.8100858,
                    35.0867577
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Nashville GI Specialists, Nashville, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.7742984,
                    36.1622767
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Vanderbilt University Medical Center, Nashville, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.80163418092431,
                    36.14092375
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Baylor University Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.78199034999996,
                    32.7865443
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Texas Medical Branch, Galveston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94.77627329985782,
                    29.31201835
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Memorial Hermann Hospital, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.3971077,
                    29.7144958
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Vermont, Burlington, Vermont, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.19414679705882,
                    44.4737365
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Digestive and Liver Disease Specialists, Norfolk, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.2602336,
                    36.8968052
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "McGuire Research Institute, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.43428,
                    37.5385087
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Seattle Gastroenterology Associates, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.330062,
                    47.6038321
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Calgary, Calgary, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -114.1283072,
                    51.0783651
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Alberta Hospital, Edmonton, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -113.52319456480116,
                    53.5206381
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Health Sciences Centre, Winnipeg, Manitoba, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97.15989306350204,
                    49.9039751
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "London Health Sciences Centre, London, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.243372,
                    42.9832406
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Mount Sinai Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.39033976650668,
                    43.657443650000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Exploratory Efficacy Study of NEUROSTEM\u00ae Versus Placebo in Patients With Alzheimer's Disease",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02054208",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 95, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2014-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)",
                "aff": "Miami VA Healthcare System, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04629105",
                "enrolled": 70,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 82, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2020-07-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)",
                "aff": "University of Maryland Medical Center, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04629105",
                "enrolled": 70,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 82, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2020-07-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.62439437177966,
                    39.28827365
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)",
                "aff": "Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04629105",
                "enrolled": 70,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 82, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2020-07-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.26771223216093,
                    36.08983775
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease",
                "aff": "Brain Matters Research, Delray Beach, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02600130",
                "enrolled": 33,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 106, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2016-09-10",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.0728201,
                    26.4614625
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease",
                "aff": "University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02600130",
                "enrolled": 33,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 106, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2016-09-10",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease",
                "aff": "Miami Jewish Health, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02600130",
                "enrolled": 33,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 106, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2016-09-10",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19308907007704,
                    25.82314155
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Mercy Gilbert Medical Center / Catholic Health Care West, Gilbert, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111.7890373,
                    33.3527632
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Arizona, Tucson, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -110.951744125426,
                    32.2356427
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "UC Davis Medical Center, Sacramento, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -121.493895,
                    38.5810606
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of California - San Diego (UCSD), San Diego, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.23112468377349,
                    32.87924375
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Mount Sinai Medical Center, Miami Beach, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.14087344557441,
                    25.81338075
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.27870688083459,
                    25.71727245
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.66910060446992,
                    41.87352605
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "The Care Group, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.1583502,
                    39.7683331
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91.5299106,
                    41.6612561
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Cotton-O'Neil Clinical Research Center, Topeka, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.677556,
                    39.049011
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Maryland Hospital, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.62461428102453,
                    39.28795845
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Tufts Medical Center, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.06308467518953,
                    42.349439700000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Baystate Medical Center, Springfield, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72.60300615153007,
                    42.12152205
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "UMass Memorial Medical Center, Worcester, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.78967731415291,
                    42.285242
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "William Beaumont Hospital, Royal Oak, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.19410267979237,
                    42.5150439
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Michigan Cardiovascular Institute, Saginaw, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.9490365,
                    43.4200387
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Minneapolis Heart Institute, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93.26112110540949,
                    44.95249955
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74.4518173,
                    40.4862174
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University at Buffalo - Buffalo General Hospital, Buffalo, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.8783922,
                    42.8867166
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Stony Brook University Medical Center, Stony Brook, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.140943,
                    40.9256538
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.2440518,
                    36.0998131
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "The Lindner Research Center, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.5124602,
                    39.1014537
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "The Ohio State University Medical Center, Columbus, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.01873232331297,
                    39.9950822
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Oregon Health & Science University, Portland, Oregon, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.68649573676775,
                    45.4981929
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Penn State University - Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.67321279234645,
                    40.2653862
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Drexel University College of Medicine, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.16467887210737,
                    39.95673585
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Allegheny General Hospital, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.0033113928861,
                    40.45696955
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "The Stern Cardiovascular Center, Germantown, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.8100858,
                    35.0867577
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Austin Heart P.A., Austin, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97.7436995,
                    30.2711286
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Texas Health Science Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.4031517,
                    29.7029914
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Fletcher Allen Health Care, Burlington, Vermont, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.18869989999999,
                    44.473342900000006
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Wisconsin School of Medicine, Madison, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.3837613,
                    43.074761
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "McGill University Health Centre, Montreal, Quebec, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.5999506480536,
                    45.47401605
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Stem Cell Therapy in Patients With Autism",
                "aff": "Shandong Jiaotong Hospital, Jinan, Shandong, China",
                "url": "https://ClinicalTrials.gov/show/NCT01343511",
                "enrolled": 37,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 75, 45)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2009-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    117.1140042,
                    36.6507007
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "David Geffen School of Medicine at UCLA, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 98, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-03-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.242766,
                    34.0536909
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 98, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-03-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.3406288,
                    33.8358492
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "American Health Research, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 98, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-03-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.8430827,
                    35.2272086
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "Upstate Pharmaceutical Research, Greenville, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 98, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-03-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.3984882,
                    34.851354
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "Spartanburg Medical Research, Spartanburg, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 98, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-03-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.9320157,
                    34.9498007
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "Vermont Lung Center, University of Vermont, Burlington, Vermont, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 98, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-03-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.19414679705882,
                    44.4737365
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Prochymal\u00ae for the Salvage of Treatment-Refractory Acute GVHD Patients",
                "aff": "Duke University, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00284986",
                "enrolled": 11,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 81, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2005-10-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.94422972195878,
                    36.00015569999999
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions",
                "aff": "Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04684602",
                "enrolled": 5000,
                "radius": 80,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 86, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12920,
                "paneLabel": "pane12920",
                "start": "2020-07-09",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.396466,
                    34.0211224
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)",
                "aff": "Andrews Institute, Gulf Breeze, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818737",
                "enrolled": 480,
                "radius": 31,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 92, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12969,
                "paneLabel": "pane12969",
                "start": "2019-03-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.15941431829276,
                    30.3588342
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)",
                "aff": "The Emory Clinic, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818737",
                "enrolled": 480,
                "radius": 31,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 92, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12969,
                "paneLabel": "pane12969",
                "start": "2019-03-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.3902644,
                    33.7489924
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)",
                "aff": "Duke University, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818737",
                "enrolled": 480,
                "radius": 31,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 92, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12969,
                "paneLabel": "pane12969",
                "start": "2019-03-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.94422972195878,
                    36.00015569999999
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)",
                "aff": "Sanford Health, Fargo, North Dakota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818737",
                "enrolled": 480,
                "radius": 31,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 92, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12969,
                "paneLabel": "pane12969",
                "start": "2019-03-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.79903467206503,
                    46.90020925
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)",
                "aff": "Sanford Health, Sioux Falls, South Dakota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818737",
                "enrolled": 480,
                "radius": 31,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 92, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12969,
                "paneLabel": "pane12969",
                "start": "2019-03-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.72368,
                    43.5499637
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Biochemical Correction of Severe EB by Allo HSCT and \"Off-the-shelf\" MSCs",
                "aff": "University of Minnesota Masonic Cancer Center and Medical Center, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01033552",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 70, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2010-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93.2654692,
                    44.9772995
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia",
                "aff": "Dankook University Hospital, Cheonan, Chung Nam, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03676400",
                "enrolled": 84,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 69, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2018-09-02",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49.132971,
                    55.8215537
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intra-Osseous Co-Transplant of UCB and hMSC",
                "aff": "Case Comprehensive Cancer Center, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02181478",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 64, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2015-07-22",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.6936813,
                    41.4996562
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST)",
                "aff": "Belfast Health and Social Care Trust, Royal Hospitals, Belfast, Northern Ireland, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT03042143",
                "enrolled": 129,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 98, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12979,
                "paneLabel": "pane12979",
                "start": "2019-01-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5.9557889,
                    54.5952266
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Menstrual Blood Stem Cells in Severe Covid-19",
                "aff": "Avicenna Research Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05019287",
                "enrolled": 29,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 80, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2021-04-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51.41666085836621,
                    35.7447916
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Alabama Birmingham (UAB) Hospital, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.8024326,
                    33.5206824
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "UCLA Medical Center, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.445498,
                    34.0655633
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of California Medical Center, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.4574026768062,
                    37.76307
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Rocky Mountain Cancer Center, Denver, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -104.96563217321044,
                    39.74521575
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Florida, Gainesville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.34901329340119,
                    29.6328784
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Emory University, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.32778960627682,
                    33.795867650000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Northside Hospital, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.35450682100918,
                    33.9102901
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Northwestern Center for Clinical Research, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.6244212,
                    41.8755616
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.66910060446992,
                    41.87352605
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Chicago Hospitals, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.60488420632774,
                    41.7904074
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Loyola University Medical Center, Maywood, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.83524274972845,
                    41.85901495
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Indiana University Cancer Center, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.1583502,
                    39.7683331
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "St. Francis Cancer Center, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.1583502,
                    39.7683331
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Louisville, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85.75770751081866,
                    38.21332235
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Tufts New England Medical Center, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.060511,
                    42.3554334
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.06875296664998,
                    42.36286045
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Dana Farber Cancer Institute, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.10769331557015,
                    42.33762635
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.10970567673255,
                    42.33837185
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.0466403,
                    42.3315509
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Mayo Medical Center, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92.4630182,
                    44.0234387
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Mississippi Medical Center, Jackson, Mississippi, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.1725205723653,
                    32.32938955
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Kansas City Cancer Center, Lee's Summit, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94.3821295,
                    38.9107156
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Washington University School of Medicine, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.25886733971312,
                    38.6360711
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Roswell Park Cancer Institute, Buffalo, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.8783922,
                    42.8867166
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Memorial Sloan Kettering Cancer Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.95695491103503,
                    40.7644418
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Mount Sinai School of Medicine, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "New York Presbyterian Hospital, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of North Carolina Hospitals, Chapel Hill, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.05578,
                    35.9131542
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Duke University Health System, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.9018053,
                    35.996653
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.2440518,
                    36.0998131
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Jewish Hospital, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.49969939578145,
                    39.13742135
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Ohio State University, Columbus, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.02866465596318,
                    40.00570905
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.67321279234645,
                    40.2653862
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Abramson Cancer Center, University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.1635262,
                    39.9527237
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Thomas Jefferson University, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.15805656266755,
                    39.9489114
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.94609007817003,
                    40.4612409
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Oncology Hematology Association, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.6243098,
                    40.3693889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Pittsburgh Cancer Centers, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.6243098,
                    40.3693889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Medical University of South Carolina(MUSC), Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.9402728,
                    32.7876012
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Baylor University Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.78199034999996,
                    32.7865443
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "MD Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.39782993506569,
                    29.7076703
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Texas Transplant Institute, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98.4951405,
                    29.4246002
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Virginia Commonwealth University, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.45406089907547,
                    37.54612465
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Fred Hutchinson Cancer Research Center, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.33067301841714,
                    47.6277525
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Medical College of Wisconsin, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88.02245316747553,
                    43.04386705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Adelaide Hospital, Adelaide, South Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    138.58717276889342,
                    -34.9205767
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Melbourne Hospital, Parkville, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144.9559783,
                    -37.7994515
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Perth Hospital, Perth, Western Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    115.86593154993494,
                    -31.95323205
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "St. Vincent's Hospital, Darlinghurst, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    151.2211881,
                    -33.8792689
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Brisbane Hospital, Herston, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    153.02681090546656,
                    -27.4477301
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Peter Lougheed Centre, Calgary, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -113.9845622352017,
                    51.079522100000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Ottawa Hospital, Ottawa, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.72059219183689,
                    45.39147405
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Princess Margaret Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.39064248533157,
                    43.65816355
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)",
                "aff": "University of Florida, Gainesville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04723303",
                "enrolled": 22,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 77, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-09-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.34901329340119,
                    29.6328784
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Children's Hospital Los Angeles, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 103, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.29008014420512,
                    34.0976912
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Children's Hospital of Orange County, Orange, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 103, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.8660898647464,
                    33.7809052
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "University of California at San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 103, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.419906,
                    37.7790262
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Children's Hospital Colorado Center for Cancer/Blood Disorders, Aurora, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 103, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -104.8309947,
                    39.7405111
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Alfred I. DuPont Hospital for Children of the Nemours Foundation, Wilmington, Delaware, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 103, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.546589,
                    39.7459468
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Miami Children's Research Institute, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 103, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 103, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.6244212,
                    41.8755616
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Children's Hospital of Michigan, Detroit, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 103, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.05478802048023,
                    42.351889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "University of Mississippi Medical Center, Jackson, Mississippi, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 103, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.1725205723653,
                    32.32938955
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Washington University, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 103, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.258941,
                    38.634807
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Columbia University Medical Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 103, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Memorial Sloan Kettering Cancer Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 103, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.95695491103503,
                    40.7644418
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Albert Einstein College of Medicine, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 103, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.84572204231365,
                    40.85277655
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Duke University Medical Center, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 103, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.93676230303336,
                    36.0095073
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Oregon University, Portland, Oregon, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 103, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.6753224,
                    45.5143904
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 103, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.94714193501349,
                    32.7842965
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Texas Transplant Institute, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 103, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98.4951405,
                    29.4246002
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Virginia Commonwealth University, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 103, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.45406089907547,
                    37.54612465
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Fred Hutchinson Cancer Research, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 103, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.33067301841714,
                    47.6277525
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Medical College of Wisconsin, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 103, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88.02245316747553,
                    43.04386705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS",
                "aff": "H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re - APHP, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT04333368",
                "enrolled": 47,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 99, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2020-04-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2.3200410217200766,
                    48.8588897
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS",
                "aff": "H\u00f4pital Europ\u00e9en Georges Pompidou - APHP, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT04333368",
                "enrolled": 47,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 99, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2020-04-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2.3200410217200766,
                    48.8588897
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Children's Hospital Los Angeles, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 59, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.29008014420512,
                    34.0976912
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "CHOC Children's Hospital of Orange County, Orange, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 59, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.8704931,
                    33.7500378
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "UCSF Benioff Children's Hospital, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 59, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.3896641,
                    37.7647716
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Children's Hospital Colorado Center for Cancer/Blood Disorders, Aurora, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 59, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -104.8309947,
                    39.7405111
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Alfred I. duPont Hospital for Children of the Nemours Foundation, Wilmington, Delaware, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 59, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.546589,
                    39.7459468
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Miami Children's Research Institute, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 59, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 59, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.6244212,
                    41.8755616
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Children's Hospital of Michigan, Detroit, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 59, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.05478802048023,
                    42.351889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "University of Mississippi Medical Center, Jackson, Mississippi, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 59, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.1725205723653,
                    32.32938955
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Washington University, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 59, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.258941,
                    38.634807
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Columbia University Medical Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 59, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Memorial Sloan Kettering Cancer Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 59, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.95695491103503,
                    40.7644418
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "The Children's Hospital at Montefiore, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 59, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Duke University Medical Center, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 59, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.93676230303336,
                    36.0095073
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Oregon Health & Science University, Portland, Oregon, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 59, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.68649573676775,
                    45.4981929
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 59, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.94714193501349,
                    32.7842965
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Texas Transplant Institute, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 59, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98.4951405,
                    29.4246002
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Virginia Commonwealth University, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 59, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.45406089907547,
                    37.54612465
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Fred Hutchinson Cancer Center, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 59, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.33067301841714,
                    47.6277525
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Medical College of Wisconsin, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 59, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88.02245316747553,
                    43.04386705
                ]
            }
        }
    ]
}